Differential effects of transforming growth factor-beta 1 on interleukin-1-induced cellular inflammation and vascular permeability in the rabbit retina
- PMID: 8862131
- DOI: 10.1016/s0165-5728(96)00103-8
Differential effects of transforming growth factor-beta 1 on interleukin-1-induced cellular inflammation and vascular permeability in the rabbit retina
Abstract
Intra-vitreal injection of 300 U of interleukin (IL)-1 beta into the rabbit eye induces an inflammation of the retina characterized by hemorrhage, monocyte and neutrophil infiltration, and an increase in vascular permeability that peaks 24 h post-injection. Since the epiretinal vessels involved in this inflammation form part of the blood-retina barrier, we used this model to investigate the effects of the immunosuppressive cytokine TGF beta 1 on inflammation within the context of the central nervous system. We found that intra-vitreal injection of 1 microgram rh TGF beta administered concomitantly with rh IL-1 beta significantly reduced IL-1 beta-induced hemorrhage by 78%, and monocyte and neutrophil infiltration by 53% and 62%, respectively. In contrast, TGF beta did not reduce the IL-1 beta-induced increase in vascular permeability. However, TGF beta by itself caused a statistically significant increase in serum proteins in perfused tissues of the eye, to give a 3.1 +/- 0.4 fold increase in protein content over control values. No cellular inflammation accompanied this alteration in vascular permeability. These data indicate that whereas the local administration of TGF beta may be an effective inhibitor of cellular inflammation in the CNS, the effects on alterations in vascular permeability and accumulation of serum proteins may be more complex.
Similar articles
-
Ultrastructural studies of the blood-retina barrier after exposure to interleukin-1 beta or tumor necrosis factor-alpha.Lab Invest. 1994 Jun;70(6):850-61. Lab Invest. 1994. PMID: 8015289
-
Ultrastructural analysis of interleukin-1 beta-induced leukocyte recruitment to the rat retina.Invest Ophthalmol Vis Sci. 1997 Jan;38(1):25-35. Invest Ophthalmol Vis Sci. 1997. PMID: 9008627
-
Chronic inflammatory effects of interleukin-1 on the blood-retina barrier.J Neuroimmunol. 1992 Dec;41(2):167-76. doi: 10.1016/0165-5728(92)90067-u. J Neuroimmunol. 1992. PMID: 1469076
-
Interleukin-1 beta-induced disruption of the retinal vascular barrier of the central nervous system is mediated through leukocyte recruitment and histamine.Am J Pathol. 1997 Jan;150(1):329-40. Am J Pathol. 1997. PMID: 9006348 Free PMC article.
-
The ordered array of perivascular macrophages is disrupted by IL-1-induced inflammation in the rabbit retina.Glia. 1996 Aug;17(4):307-16. doi: 10.1002/(SICI)1098-1136(199608)17:4<307::AID-GLIA5>3.0.CO;2-W. Glia. 1996. PMID: 8856327
Cited by
-
Anti-angiogenic Therapy for Retinal Disease.Handb Exp Pharmacol. 2017;242:271-307. doi: 10.1007/164_2016_78. Handb Exp Pharmacol. 2017. PMID: 27783271 Free PMC article.
-
Cytokine-induced inflammation in the central nervous system revisited.Neurochem Res. 1998 Mar;23(3):349-59. doi: 10.1023/a:1022457500700. Neurochem Res. 1998. PMID: 9482247 Review.
-
Advances in islet encapsulation technologies.Nat Rev Drug Discov. 2017 May;16(5):338-350. doi: 10.1038/nrd.2016.232. Epub 2016 Dec 23. Nat Rev Drug Discov. 2017. PMID: 28008169 Free PMC article. Review.
-
Interleukin-6, age, and corpus callosum integrity.PLoS One. 2014 Sep 4;9(9):e106521. doi: 10.1371/journal.pone.0106521. eCollection 2014. PLoS One. 2014. PMID: 25188448 Free PMC article.
-
Inflammatory cytokines as mediators of retinal endothelial barrier dysfunction in non-infectious uveitis.Clin Transl Immunology. 2023 Dec 12;12(12):e1479. doi: 10.1002/cti2.1479. eCollection 2023. Clin Transl Immunology. 2023. PMID: 38090668 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources